The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease

Abstract Context This commentary discusses the implications of disease-modifying treatments for Alzheimer’s disease which seem likely to appear in the next few years and results from a meeting of British experts in neurodegenerative diseases in Edinburgh. The availability of such treatments would he...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Craig W. Ritchie, Tom C. Russ, Sube Banerjee, Bob Barber, Andrew Boaden, Nick C. Fox, Clive Holmes, Jeremy D. Isaacs, Ira Leroi, Simon Lovestone, Matt Norton, John O’Brien, Jim Pearson, Richard Perry, James Pickett, Adam D. Waldman, Wai Lup Wong, Martin N. Rossor, Alistair Burns
Formato: Artigo
Lenguaje:Inglês
Publicado: BMC 2017-10-01
Colección:Alzheimer’s Research & Therapy
Materias:
Dementia
Alzheimer’s disease
Therapeutics
Disease-modification
Service redesign
Clinical trials
Acceso en línea:http://link.springer.com/article/10.1186/s13195-017-0312-4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares